Fred Hutchinson announces Harold M. Weintraub Graduate Student Award winners

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Fred Hutchinson Cancer Research Center today announced the recipients of the Harold M. Weintraub Graduate Student Award, which recognizes the outstanding achievement of graduate studies in the biological sciences. The thirteen award recipients were chosen by a selection committee of Fred Hutch faculty members and students for the quality, originality and significance of their work, and for representation of a diverse range of research topics.

The 2017 awardees attend universities across the U.S. — from Caltech to the Massachusetts Institute of Technology to Baylor College — and one international recipient who attends the Weizmann Institute of Science in Israel. Their studies explore areas as far ranging as evolvability and order in the nervous system, how microbiome dynamics may control host immunity and metabolism and innovative treatment strategies for mitochondrial disease.

Named for the late Harold Weintraub, the award honors Weintraub’s scientific leadership in the field of molecular biology and his legacy as an extraordinary mentor, colleague, collaborator and friend. He was passionate about understanding how a certain protein drives cell development, investigating RNA interference, and applying molecular manipulations pioneered in his lab to other areas of medical research, such as stem cell transplantation.

Weintraub helped found the Basic Sciences Division at Fred Hutch and died of brain cancer in 1995 at age 49.

Weintraub Award recipients will travel to Seattle for an award symposium held May 5 on the Fred Hutch campus. At the symposium, recipients will give scientific presentations and have the opportunity to convene with other students and faculty members.

Each awardee will receive a certificate, travel expenses and honorarium from The Weintraub and Groudine Fund, created to foster intellectual exchange through supporting programs for graduate students, fellows and visiting scholars.

2017 Harold M. Weintraub Graduate Student Award recipients:

  • Thomas Bartlett
    Molecular Biology Princeton University

  • Lynne Chantranupong
    Biology Massachusetts Institute of Technology

  • Raphael Cohn
    Neurophysiology and Behavior Rockefeller University

  • Kelsie Eichel
    Cellular Biology University of California, San Francisco

  • Qing Feng
    Molecular and Cellular Biology Fred Hutch/University of Washington

  • Isha Jain
    Health Sciences and Technology Massachusetts Institute of Technology

  • Daniel Lin
    Biochemistry and Molecular Biophysics Caltech

  • Lucy Liu
    Neuroscience Baylor College of Medicine

  • Siew Cheng Phua
    Cellular and Molecular Biology Johns Hopkins School of Medicine

  • Dheeraj Roy
    Brain & Cognitive Sciences Massachusetts Institute of Technology

  • Sukrit Silas
    Chemical and Systems Biology Stanford University

  • Christoph Thaiss
    Immunology Weizmann Institute of Science

  • Candice Yip
    Neurobiology Harvard Medical School

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login